Clarus Therapeutics Holdings, Inc.

Clarus Therapeutics Holdings, Inc.verified

CRXT

Price:

$0.0475

Market Cap:

$0

Clarus Therapeutics Holdings, Inc., a pharmaceutical company, focuses on the development and commercialization of oral testosterone replacement therapy in the United States. It offers JATENZO, a soft gel oral formulation of testosterone undecanoate for treating hypogonadal men. The company has a licensing agreement with HavaH Therapeutics for product to treat androgen therapies for inflammatory breast disease and certain forms of breast cancer; and license agreement with The Royal Institution for the Advancement of Learning/McGill University to develop and commercialize McGill's proprietary technology designed to treat conditions associated with CoQ10 deficiencies in humans. Clarus Therapeut...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2021-09-07

Stock Exchange

NASDAQ

Ticker

CRXT

The PE Ratio as of May 2024 (TTM) for Clarus Therapeutics Holdings, Inc. (CRXT) is -0.02

According to Clarus Therapeutics Holdings, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.02. This represents a change of -98.61% compared to the average of -1.22 of the last 4 quarters.

Clarus Therapeutics Holdings, Inc. (CRXT) Historical PE Ratio (quarterly & annually)

How has CRXT PE Ratio performed in the past?

The mean historical PE Ratio of Clarus Therapeutics Holdings, Inc. over the last ten years is -0.52. The current -0.02 PE Ratio has changed 228.41% with respect to the historical average. Over the past ten years (40 quarters), CRXT's PE Ratio was at its highest in in the September 2020 quarter at 7.93. The PE Ratio was at its lowest in in the September 2021 quarter at -4.41.

Quarterly (TTM)
Annual

Average

-0.52

Median

-0.52

Minimum

-1.03

Maximum

0

Clarus Therapeutics Holdings, Inc. (CRXT) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Clarus Therapeutics Holdings, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 0%

Maximum Annual PE Ratio = 0

Minimum Annual Increase = -Infinity%

Minimum Annual PE Ratio = -1.03

Quarterly (TTM)
Annual
YearPE RatioChange
2021-1.03-Infinity%

Clarus Therapeutics Holdings, Inc. (CRXT) Average PE Ratio

How has CRXT PE Ratio performed in the past?

The current PE Ratio of Clarus Therapeutics Holdings, Inc. (CRXT) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

-0.52

5-year avg

-0.52

10-year avg

-0.52

Clarus Therapeutics Holdings, Inc. (CRXT) PE Ratio vs. Peers

How is CRXT’s PE Ratio compared to its peers?

Clarus Therapeutics Holdings, Inc.’s PE Ratio is

CompanyPE RatioMarket cap

Build a custom stock screener for Clarus Therapeutics Holdings, Inc. (CRXT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Clarus Therapeutics Holdings, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Clarus Therapeutics Holdings, Inc. (CRXT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Clarus Therapeutics Holdings, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the PE Ratio?

How can you use the PE Ratio?

What is Clarus Therapeutics Holdings, Inc.'s PE Ratio?

How is the PE Ratio calculated for Clarus Therapeutics Holdings, Inc. (CRXT)?

What is the highest PE Ratio for Clarus Therapeutics Holdings, Inc. (CRXT)?

What is the 3-year average PE Ratio for Clarus Therapeutics Holdings, Inc. (CRXT)?

What is the 5-year average PE Ratio for Clarus Therapeutics Holdings, Inc. (CRXT)?

How does the current PE Ratio for Clarus Therapeutics Holdings, Inc. (CRXT) compare to its historical average?